The End Brain Cancer Initiative Shares PCNSL Patient Friendly Resource About ONO PHARMA Phase II PROSPECT Study Results
EBCI helps PCNSL patients understand the results from ONO PHARMA's recent phase II PROSPECT study, which tested the safety and efficacy of tirabrutinib. REDMOND, WA, UNITED STATES, December 23, 2025 /EINPresswire.com/ -- ONO PHARMA recently …